← Back to Ind Swift Laboratories Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

INDSWFTLABPharmaceuticals

Ind Swift Laboratories Ltd — Financial Ratios & Key Metrics

₹131.43

+0.97%

P/E Ratio26.57xIndustry: 31.77x

ROE0.18%Return on equity

ROCE0.78%Return on capital

Debt/Equity0.02Low debt

💎

Valuation & Profitability

P/E Ratio

26.57x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹787.55 (Cr)

Sales Growth 5Y

-6.35%

Profit Growth 5Y

15.81%

EPS Growth 5Y

15.79%

OPM 5Y Avg

16.66%

📉

Price Returns

1 Month

-6.12%

3 Months

-2.66%

6 Months

+2.35%

1 Year

+1.86%

52W Low

₹69

Current

₹131

52W High

₹152

75% of 52-week range — Near highs

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹130

▲ Price above SMA 50 — Bullish

SMA 200

₹109

▲ Long-term uptrend

Volume Signal

147% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Ind Swift Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.